Cabaletta Bio

CABA53

Penny Stock

$3.03arrow_drop_down20.10%-$0.75

Penny Stock

CABA53

$3.03

arrow_drop_down20.10%-$0.75

Penny Stock

Performance History

Key Stats
Open	$4.41
Prev. Close	$4.46
EPS	-1.91
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$210.04M
PE Ratio	-

	LOW	HIGH
Day Range	4.21	4.46
52 Week Range	3.47	26.35

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-1.91

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Cabaletta Bio (CABA)

Cabaletta Bio Inc (CABA) is a biopharmaceutical company focused on the discovery and development of novel cell therapies for patients with B cell-mediated autoimmune diseases. The company is dedicated to harnessing the power of the immune system to target and eliminate the specific cells responsible for driving these debilitating diseases. With a mission to transform the treatment landscape for patients, Cabaletta Bio is advancing a pipeline of potential therapies that have the potential to provide long-lasting remission and improve the quality of life for those affected.

As of the latest available information, the stock price history of Cabaletta Bio Inc (CABA) shows fluctuations over time. Investors should consider this volatility when making investment decisions. However, it is worth noting that past performance is not indicative of future results. Therefore, investors should conduct their thorough research and consult with a financial advisor before making any investment decisions.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Steven A. Nichtberger M.D.
Headquarters: Philadelphia
Employees: 77
Exchange: NASDAQ

Keep an eye on Cabaletta Bio

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Cabaletta Bio 's (CABA) price per share?

The current price per share for Cabaletta Bio (CABA) is $3.03. The stock has seen a price change of -$0.76 recently, indicating a -20.11% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Cabaletta Bio (CABA)?

For Cabaletta Bio (CABA), the 52-week high is $26.35, which is 769.64% from the current price. The 52-week low is $2.97, the current price is 1.99% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Cabaletta Bio (CABA) a growth stock?

Cabaletta Bio (CABA) has shown an average price growth of -4.94% over the past three years. It has received a score of 91 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Cabaletta Bio as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Cabaletta Bio (CABA) stock price performance year to date (YTD)?

As of the latest data, Cabaletta Bio (CABA) has a year-to-date price change of -86.33%. Over the past month, the stock has experienced a price change of -28.71%. Over the last three months, the change has been -30.82%. Over the past six months, the figure is -73.02%. Looking at a longer horizon, the five-year price change stands at -76.98%.

help

Is Cabaletta Bio (CABA) a profitable company?

Cabaletta Bio (CABA) has a net income of -$67.68M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$74.66M. Furthermore, the EBITDA is -$98.61M.

help

What is the market capitalization of Cabaletta Bio (CABA)?

Cabaletta Bio (CABA) has a market capitalization of $148.04M. The average daily trading volume is 3.11, indicating the stock's liquidity and investor engagement.